Tudor Investment Corp Et Al decreased its position in shares of Halyard Health Inc (NYSE:HYH) by 63.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,260 shares of the company’s stock after selling 14,601 shares during the period. Tudor Investment Corp Et Al’s holdings in Halyard Health were worth $305,000 as of its most recent filing with the SEC.
Other institutional investors have also recently modified their holdings of the company. DUPONT CAPITAL MANAGEMENT Corp raised its stake in Halyard Health by 57.9% in the third quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 20,623 shares of the company’s stock valued at $715,000 after buying an additional 7,560 shares in the last quarter. Nordea Investment Management AB bought a new stake in Halyard Health during the third quarter valued at $461,000. Chicago Equity Partners LLC raised its stake in Halyard Health by 2.5% in the third quarter. Chicago Equity Partners LLC now owns 226,580 shares of the company’s stock valued at $7,853,000 after buying an additional 5,505 shares in the last quarter. Shell Asset Management Co. bought a new stake in Halyard Health during the third quarter valued at $1,074,000. Finally, Great West Life Assurance Co. Can raised its stake in Halyard Health by 9.9% in the third quarter. Great West Life Assurance Co. Can now owns 28,898 shares of the company’s stock valued at $1,001,000 after buying an additional 2,604 shares in the last quarter. 87.50% of the stock is owned by hedge funds and other institutional investors.
Shares of Halyard Health Inc (NYSE:HYH) opened at 38.94 on Monday. Halyard Health Inc has a 1-year low of $26.05 and a 1-year high of $41.84. The stock’s 50 day moving average price is $39.83 and its 200 day moving average price is $36.92. The company has a market capitalization of $1.82 billion, a price-to-earnings ratio of 45.81 and a beta of 1.87.
Halyard Health (NYSE:HYH) last posted its quarterly earnings data on Monday, February 27th. The company reported $0.50 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.06. Halyard Health had a net margin of 2.80% and a return on equity of 8.63%. The firm earned $410 million during the quarter, compared to analysts’ expectations of $401.72 million. During the same quarter in the previous year, the company posted $0.57 EPS. Halyard Health’s revenue was up 2.1% on a year-over-year basis. Analysts expect that Halyard Health Inc will post $1.84 EPS for the current year.
Your IP Address:
HYH has been the subject of several research reports. Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $41.00 price objective for the company in a research note on Wednesday, January 4th. Stifel Nicolaus raised their price objective on Halyard Health from $38.00 to $45.00 and gave the stock a “buy” rating in a research note on Tuesday, February 28th. JMP Securities lowered Halyard Health from an “outperform” rating to a “market perform” rating and set a $38.00 price objective for the company. in a research note on Friday, January 6th. Stephens lowered Halyard Health from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 28th. Finally, Deutsche Bank AG lowered Halyard Health from a “buy” rating to a “hold” rating and set a $35.00 price objective for the company. in a research note on Thursday, December 15th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $39.75.
Halyard Health Company Profile
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc (NYSE:HYH).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/tudor-investment-corp-et-al-reduces-position-in-halyard-health-inc-hyh/1708752.html
Receive News & Ratings for Halyard Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.